+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase-type plasminogen activator- induced transmembrane signalling, an important contributor to human aortic smooth muscle cell growth?



Urokinase-type plasminogen activator- induced transmembrane signalling, an important contributor to human aortic smooth muscle cell growth?



Circulation 94(8 Suppl. ): I466




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144276

Download citation: RISBibTeXText


Related references

Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell. Journal of Thrombosis and Haemostasis 10(10): 2158-2167, 2013

Endothelial cell growth supplement ecgs stimulates urokinase type plasminogen activator u pa production by human pulmonary artery smooth muscle cells hpasmc. Journal of Cellular Biochemistry Suppl. (14 Part E): 87, 1990

Interleukin-4 Modulation of Platelet-Derived Growth Factor-Induced Smooth Muscle Cell Urokinase Plasminogen Activator. Journal of Thrombosis and Thrombolysis 5(2): 119-123, 2000

Urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes are not internalized upon binding to the urokinase-type-plasminogen-activator receptor in THP-1 cells: Interaction of urokinase-type plasminogen activator/type-2 plasminogen-activator inhibitor complexes with the cell surface. European Journal of Biochemistry 233(2): 514-519, 1995

Gamma interferon attenuates smooth muscle cell urokinase plasminogen activator and migration induced by basic fibroblast growth factor. Circulation 94(8 Suppl. ): I512, 1996

Differential effects of acute and chronic wound fluids on urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and tissue-type plasminogen activator in cultured human keratinocytes and fibroblasts. Wound Repair & Regeneration 9(4): 314-322, July-August, 2001

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. Journal of Urology 174(2): 461-465, 2005

Regulation of plasminogen activator inhibitor-1 secretion by urokinase and tissue plasminogen activator in rat epithelioid-type smooth muscle cells. British Journal of Haematology 117(1): 151-158, 2002

Interleukin-4 modulation of smooth muscle cell urokinase-type plasminogen activator production. Journal of Investigative Medicine 43(Suppl. 2): 310A, 1995

Anti-fibrotic action of hepatocyte growth factor by up-regulation of matrix metalloprotease-1 and urokinase-type plasminogen activator in human fibroblasts and vascular smooth muscle cells. Circulation 98(17 Suppl. ): I810, Oct 27, 1998

Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells. Oncology Reports 17(5): 1259-1268, 2007

Urokinase-Type plasminogen activator is involved in smooth muscle cell migration in wounded cultures. Fibrinolysis 8(Suppl. 1): 148, 1994

Human vascular smooth muscle cells express urokinase type plasminogen activator receptors. Journal of the American College of Cardiology 19(3 Suppl. A): 165A, 1992

The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells. Journal of Cell Science 115(Pt 9): 1961-1971, 2002